PROFILE

Dirk Arnold completed his specialist training at Charité, Humboldt University in Berlin. Subsequently, he specialized as a medical oncologist and palliative care specialist at Martin Luther University Halle-Wittenberg in Halle, Germany. He has held the positions of Professor and Head of the Gastrointestinal Cancer Unit at Martin Luther University Halle-Wittenberg. In 2010, he was appointed Professor of Oncology at the University of Hamburg and held the position of Director of the University Cancer Center Hamburg. From 2015 to 2017, he served as Director of Oncology Services at CUF in Lisbon, Portugal. Since 2017, he has been Director of Asklepios Tumorzentrum Hamburg, a large network cancer center, and Chairman of the Oncology Department at AK Altona, Hamburg. His main research interests include the treatment of gastrointestinal and genitourinary cancers, specifically in molecular-targeted therapies, immunotherapy, multimodal treatment strategies, and early drug development. He is also interested in research network structures and methodologies of clinical research and benefit evaluation procedures, as well as palliative and supportive care. He served for over 10 years as Chair of the Colorectal Cancer Study Group of the Working Group for Internal Oncology (Arbeitsgemeinschaft Internistische Onkologie [AIO]). He is a key member of several German and international cancer societies, including the European Society for Medical Oncology (ESMO), where he serves as a Council Member and Chairman of the Compliance Committee. He served as Section Editor for GI Cancers in the Guideline Committee and currently is Section Editor for GI Cancers with Annals of Oncology. He is also a Co-Chairman of the Task Force on Colorectal Cancer and a member of the board of the Gastrointestinal Cancer Study Group of the European Organisation for Research and Treatment of Cancer (EORTC). Dr. Arnold has co-authored more than 250 articles in peer-reviewed journals and more than 800 abstracts at international/national meetings.